GHRP-2 and GHRP-6 Stimulate GH Release Through Different Intracellular Mechanisms | Research

The takeaway

GHRP-2 increases intracellular cAMP and synergizes with GHRH additively, while GHRP-6 stimulates GH release without raising cAMP, confirming they use partially different signaling pathways.

GHRP-2 uses cAMP; GHRP-6 does not
Despite similar GH-releasing outcomes, GHRP-2 and GHRP-6 use partially different intracellular signaling pathways

What the researchers found

GHRP-2 increased intracellular cAMP (like GHRH) while GHRP-6 released GH without raising cAMP, revealing partially different mechanisms despite similar GH-releasing outcomes.

Why it matters

Understanding the signaling differences between GHRPs helps predict their clinical behavior, drug interactions, and optimal combination strategies.

How the study worked

In vitro study using partially purified sheep somatotrophs and rat pituitary cells. Intracellular cAMP and GH release were measured after treatment with GHRP-2, GHRP-6, and GRF (GHRH).

What this study cannot tell us

In vitro study using animal pituitary cells. Species differences may exist. Partially purified somatotrophs may not fully represent in vivo conditions.

How to read the evidence

Moderate in vitro evidence from two species with clear mechanistic distinction between the two peptides.

When this study was published

Published in 1996, this study provided important mechanistic distinctions between GHRPs that inform current understanding.

The bigger picture

This mechanistic difference between GHRP-2 and GHRP-6 helps explain their different clinical profiles and potencies, informing which peptide is best suited for different therapeutic scenarios.

Questions still open

What explains GHRP-6's ability to release GH without raising cAMP?
Does the cAMP-independent mechanism of GHRP-6 translate to different clinical effects than GHRP-2?

Common questions

Why does it matter that GHRP-2 and GHRP-6 work differently?

Even though both peptides release growth hormone through the same receptor, they activate partially different intracellular signaling cascades. This could explain differences in their potency, side effects, and how well they combine with other treatments.

What is cAMP?

Cyclic AMP (cAMP) is a key cellular messenger molecule. When GHRH activates pituitary cells, it raises cAMP, which triggers GH release. GHRP-2 also raises cAMP, but GHRP-6 bypasses this pathway entirely while still releasing GH.

Read the original research

The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.

The Journal of endocrinology, 148(2), 197-205

View on PubMed ↗

Citation

Wu, D; Chen, C; Zhang, J; Bowers, C Y; Clarke, I J. (1996). The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.. The Journal of endocrinology, 148(2), 197-205.